Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00447707 · ClinicalTrials.gov registry record · NA
Positive Choice: Prevention for Positive Health
A NA study of HIV Infections and Sexual Risk Behavior, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- NA
- Development phase
- 497
- Enrollment target
- 5
- Study locations
NCT00447707: Completed NA study of HIV Infections and Sexual Risk Behavior, sponsored by National Institute on Drug Abuse (NIDA).
NCT00447707 is a NA study of HIV Infections and Sexual Risk Behavior that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 497 participants, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (12% higher). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00447707, a NA study of HIV Infections and Sexual Risk Behavior, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- NA
- Development phase
- 497 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a randomized, controlled trial of Positive Choice, an interactive multimedia computer program, to determine whether it can detect and reduce risky behaviors among HIV-positive adults. The behaviors of interest are: unprotected anal or vaginal intercourse, illicit drug use, risky alcohol drinking, and failure to disclose HIV status to sex partners. The Positive Choice program is integrated into the routine operations of outpatient HIV clinics, where participating patients complete an in-depth risk assessment (computerized health questionnaire) before a regularly scheduled medical appointment. Participants assigned to the intervention arm receive brief, interactive risk-reduction counseling by an actor-portrayed Video Doctor and an educational worksheet. Their health care provider receives as summary cueing sheet, alerting them to the patient's risky behavior and readiness to change. Control participants complete the computerized risk assessment and receive the clinic's usual care. Three months after a baseline visit, intervention and control group patients are invited back to complete an additional risk assessment. The intervention group also receives a "booster" intervention. Six months after baseline, both groups complete a final risk assessment.
Conditions Studied
Interventions
- BEHAVIORAL Positive Choice
Study Locations (5)
California
- Adult Immunology Clinic, Highland Hospital - Oakland
- AIDS Project East Bay (APEB) - Oakland
- East Bay AIDS Center (EBAC), Alta Bates Hospital - Oakland
- Kaiser Permanente Medical Center - San Francisco
- Adult Immunology Clinic, Fairmont Hospital - San Leandro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 497 participants |
| Start Date | 2003-12 |
| Est. Completion | 2006-09 |
| Phase | NA |
What the finished NCT00447707 record still lists
NCT00447707 is an interventional study that assigns participants to a tested intervention. The registered 497 participants enrollment target is mid-sized for trials with a published cap, above the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (12% higher).
The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Positive Choice is the first listed.
NCT00447707 lists 5 locations in 1 state (California).
Frequently Asked Questions
What is clinical trial NCT00447707 about?
NCT00447707 is a clinical study titled "Positive Choice: Prevention for Positive Health". This is a randomized, controlled trial of Positive Choice, an interactive multimedia computer program, to determine whether it can detect and reduce risky behaviors among HIV-positive adults. The behaviors of interest are: unprotected anal or vaginal intercourse, illicit drug use, risky alcohol drin...
What is the current status of trial NCT00447707?
This trial is currently completed. It is a NA study. The enrollment target is 497 participants. The study started on 2003-12. Estimated completion is 2006-09.
What conditions does trial NCT00447707 study?
This clinical trial studies the following conditions: HIV Infections, Sexual Risk Behavior, Substance Use Risks.
What interventions are being tested in trial NCT00447707?
The interventions under investigation include: Positive Choice (BEHAVIORAL).
Who is sponsoring clinical trial NCT00447707?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00447707 being conducted?
This trial has 5 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00447707's enrollment target sits among peer trials
497 65th of 542 higher than 478 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03175224 · 497 participants · Phase 2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- NCT05301816 · 497 participants · NA
PDN Post Market, Multicenter, Prospective, Global Clinical Study
- NCT05766670 · 497 participants · Phase 3
Intramedullary Calcium Sulfate Antibiotic Depot
- NCT05283720 · 496 participants · Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia